BIOTRONIK SE & Co.KG Showcases DX System at Premier Healthcare Alliance’s 2013 Breakthroughs Conference and Exhibition
6/17/2013 9:15:29 AM
More...
|
BIOTRONIK SE & Co.KG Announces Positive Long Term Safety Outcomes From BIOSOLVE-I Study for DREAMS
6/7/2013 12:32:23 PM
More...
|
Orsiro From BIOTRONIK SE & Co.KG, Industry's First Hybrid Drug-Eluting Stent, Performs as Best in Class
5/30/2013 11:12:05 AM
More...
|
BIOTRONIK SE & Co.KG Announces Completion of Enrollment in IMPACT Study to Investigate Stroke Risk Reduction in Patients With Atrial Fibrillation
5/23/2013 9:15:38 AM
More...
|
BIOTRONIK SE & Co.KG Orsiro Hybrid Drug-Eluting Stent Lives Up to Abbott Laboratories (ABT)'s XIENCE PRIME™ Standards
5/22/2013 10:14:43 AM
More...
|
BIOTRONIK Champions Cardiac Research Advancements With Max Schaldach Fellowship Award in Cardiac Pacing and Electrophysiology
5/8/2013 11:14:59 AM
More...
|
FDA Approves BIOTRONIK’s Ilesto 7 ICD/CRT-D Series
5/7/2013 10:20:11 AM
More...
|
BIOTRONIK Announces Positive 12 Month Results for the Passeo-18 Lux Peripheral Vascular Paclitaxel Releasing Balloon
4/11/2013 9:43:07 AM
More...
|
BIOTRONIK Iforia is the World's First DF4 ICD/CRT-D Series Approved for MRI
3/26/2013 6:43:43 AM
More...
|
FDA Approves BIOTRONIK's Lumax 740 DX System
2/25/2013 9:03:46 AM
More...
|
|